Get startedLog in
    Picture of Harpoon Therapeutics logo

    HARP — Harpoon Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Merck to buy Harpoon Therapeutics for $680 million

    Picture of Harpoon Therapeutics logoHarpoon Therapeutics
    08/01/2024 12:33
    Jan 8 (Reuters) - Merck & Co  MRK.N  said on Monday it
would buy cancer drug developer Harpoon Therapeutics  HARP.O 
for about $680 million, reinforcing its oncology portfolio with
immunotherapies.     
    

 (Reporting by Sriparna Roy and Bhanvi Satija in Bengaluru;
Editing by Sriraj Kalluvila)
 ((Sriparna.Roy@thomsonreuters.com;))

    Recent news on Harpoon Therapeutics

    See all news